Go Pro

Cushman & Wakefield (CWK) Financials

Cushman & Wakefield logo
$13.17 -0.09 (-0.69%)
Closing price 09/9/2026 03:59 PM Eastern
Extended Trading
$13.27 +0.10 (+0.79%)
As of 09:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Cushman & Wakefield

Annual Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-434 -221 -186 0.20 -221 250 196 -35 131 88
Consolidated Net Income / (Loss)
-435 -221 -186 0.20 -221 250 196 -35 131 88
Net Income / (Loss) Continuing Operations
-435 -221 -186 0.20 -221 250 196 -35 131 88
Total Pre-Tax Income
-459 -342 -211 43 -177 340 338 -30 176 114
Total Revenue
-166 6,742 7,993 8,603 7,688 -158 9,998 9,271 9,254 9,904
Net Interest Income / (Expense)
-172 -183 -229 -151 -164 -180 -193 -281 -230 -216
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 -193 0.00 0.00 0.00
Total Interest Expense
172 183 229 151 164 180 0.00 281 230 216
Long-Term Debt Interest Expense
172 183 229 151 164 180 - 281 230 216
Total Non-Interest Income
5.90 6,925 8,222 8,754 7,852 21 10,191 9,552 9,484 10,120
Net Realized & Unrealized Capital Gains on Investments
5.90 1.40 1.90 2.60 8.30 21 85 58 37 -168
Other Non-Interest Income
- 6,924 8,220 8,751 7,844 - 10,106 9,494 9,447 10,288
Total Non-Interest Expense
295 7,095 8,207 8,564 7,865 -497 9,660 9,288 9,108 9,836
Other Operating Expenses
6,218 6,796 7,916 8,259 7,576 8,675 9,415 9,104 8,944 9,725
Depreciation Expense
261 271 290 297 264 172 147 146 122 104
Impairment Charge
32 29 1.50 7.70 57 45 8.90 38 41 6.10
Nonoperating Income / (Expense), net
2.40 11 3.50 3.50 - 1.20 - -13 29 46
Income Tax Expense
-24 -121 -25 43 44 90 142 5.40 45 26
Basic Earnings per Share
($3.07) ($1.54) ($1.09) $0.00 ($1.00) $1.12 $0.87 ($0.16) $0.57 $0.38
Weighted Average Basic Shares Outstanding
141.40M 143.90M 171.20M 217.70M 220.80M 223M 225.40M 226.90M 228.90M 231.20M
Diluted Earnings per Share
($3.07) ($1.54) ($1.09) $0.00 ($1.00) $1.10 $0.86 ($0.16) $0.56 $0.38
Weighted Average Diluted Shares Outstanding
141.40M 143.90M 171.20M 224.50M 220.80M 226.50M 228M 226.90M 232.80M 234.70M
Weighted Average Basic & Diluted Shares Outstanding
141.40M 143.90M 171.20M 217.70M 220.80M 224.55M 225.80M 227.33M 229.73M 231.82M

Quarterly Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
70 -29 14 34 113 1.90 57 51 -22 -13 53
Consolidated Net Income / (Loss)
70 -29 14 34 113 1.90 57 51 -22 -13 53
Net Income / (Loss) Continuing Operations
70 -29 14 34 113 1.90 57 51 -22 -13 53
Total Pre-Tax Income
70 -27 17 53 132 5.00 70 45 -12 -9.60 77
Total Revenue
2,512 2,138 2,232 2,301 2,583 2,243 2,431 2,541 2,688 2,483 2,705
Net Interest Income / (Expense)
-57 -59 -61 -55 -56 -52 -53 -56 -55 -49 -60
Total Interest Income
-281 0.00 0.00 0.00 - 0.00 -53 0.00 - 0.00 0.00
Total Interest Expense
-224 59 61 55 56 52 0.00 56 55 49 60
Long-Term Debt Interest Expense
- 59 61 55 56 52 - 56 55 49 60
Total Non-Interest Income
2,569 2,197 2,292 2,356 2,639 2,296 2,484 2,597 2,743 2,532 2,765
Net Realized & Unrealized Capital Gains on Investments
17 12 4.30 12 9.30 11 0.20 -8.60 -171 -4.10 2.30
Other Non-Interest Income
2,552 2,185 2,288 2,344 2,630 2,285 2,484 2,606 2,914 2,536 2,763
Total Non-Interest Expense
2,444 2,166 2,218 2,269 2,481 2,239 2,361 2,498 2,737 2,477 2,628
Other Operating Expenses
2,391 2,129 2,169 2,226 2,421 2,206 2,335 2,473 2,712 2,452 2,600
Depreciation Expense
37 33 31 29 30 27 26 26 26 25 29
Impairment Charge
15 5.00 17 14 4.60 6.50 0.00 0.00 -0.40 0.00 0.00
Nonoperating Income / (Expense), net
- 1.70 3.30 21 - 0.90 - 2.20 37 -15 0.40
Income Tax Expense
0.30 2.30 3.70 19 19 3.10 19 -6.30 10 3.00 25
Basic Earnings per Share
$0.31 ($0.13) $0.06 $0.15 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05) $0.22
Weighted Average Basic Shares Outstanding
226.90M 227.90M 229M 229.30M 228.90M 230.40M 231.40M 231.50M 231.20M 232.80M 234.40M
Diluted Earnings per Share
$0.31 ($0.13) $0.06 $0.14 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05) $0.22
Weighted Average Diluted Shares Outstanding
226.90M 227.90M 231.50M 233.40M 232.80M 232.30M 232.40M 235.90M 234.70M 232.80M 236.30M
Weighted Average Basic & Diluted Shares Outstanding
227.33M 229.05M 229.25M 229.49M 229.73M 231.29M 231.53M 231.60M 231.82M 234.30M 234.71M

Annual Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-116 29 506 -95 276 -266 -151 80 36 -31
Net Cash From Operating Activities
-335 4.40 -2.20 269 -38 550 49 152 208 340
Net Cash From Continuing Operating Activities
-335 4.40 -2.20 269 -38 550 49 152 208 340
Net Income / (Loss) Continuing Operations
-435 -221 -186 0.20 -221 250 196 -35 131 88
Consolidated Net Income / (Loss)
-435 -221 -186 0.20 -221 250 196 -35 131 88
Provision For Loan Losses
12 3.90 24 26 48 38 32 11 21 22
Depreciation Expense
261 271 290 297 264 172 147 146 122 104
Amortization Expense
13 17 13 122 128 114 112 105 94 95
Non-Cash Adjustments to Reconcile Net Income
38 42 138 49 -25 68 87 101 6.40 187
Changes in Operating Assets and Liabilities, net
-224 -107 -280 -226 -233 -92 -524 -175 -167 -156
Net Cash From Investing Activities
-138 -143 -218 -275 -258 -750 -121 49 81 -21
Net Cash From Continuing Investing Activities
-138 -143 -218 -275 -258 -750 -121 49 81 -21
Purchase of Property, Leasehold Improvements and Equipment
-77 -129 -84 -80 -41 -54 -51 -51 -41 -47
Purchase of Investment Securities
-57 -100 -49 -280 -123 -696 -139 -0.10 -0.40 -5.20
Sale and/or Maturity of Investments
3.80 86 -85 86 -94 0.20 69 100 123 32
Net Cash From Financing Activities
357 168 726 -90 572 -66 -79 -121 -253 -351
Net Cash From Continuing Financing Activities
357 168 726 -90 572 -66 -79 -121 -253 -351
Issuance of Debt
640 319 2,937 0.00 650 0.00 0.00 2,400 0.00 0.00
Repayment of Debt
-320 -164 -3,168 -39 -43 -40 -44 -2,470 -200 -300
Other Financing Activities, Net
-2.90 -11 -62 -51 -35 -26 -35 -51 -53 -51

Quarterly Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
157 -209 22 197 26 -183 -16 20 148 -178 -98
Net Cash From Operating Activities
202 -125 22 196 115 -162 9.60 236 257 -244 54
Net Cash From Continuing Operating Activities
202 -125 22 196 115 -162 9.60 236 257 -244 54
Net Income / (Loss) Continuing Operations
70 -29 14 34 113 1.90 57 51 -22 -13 53
Consolidated Net Income / (Loss)
70 -29 14 34 113 1.90 57 51 -22 -13 53
Provision For Loan Losses
5.80 2.40 5.30 3.00 10 2.80 -0.20 5.50 14 4.80 4.40
Depreciation Expense
37 33 31 29 30 27 26 26 26 25 29
Amortization Expense
28 24 26 24 21 24 24 23 24 24 24
Non-Cash Adjustments to Reconcile Net Income
26 -6.80 9.50 -12 16 3.90 8.60 22 153 55 25
Changes in Operating Assets and Liabilities, net
36 -148 -63 118 -74 -221 -106 108 64 -341 -80
Net Cash From Investing Activities
-31 -11 68 57 -33 21 11 -60 7.90 94 -36
Net Cash From Continuing Investing Activities
-31 -11 68 57 -33 21 11 -60 7.90 94 -36
Purchase of Property, Leasehold Improvements and Equipment
-16 -11 -12 -9.40 -9.30 -4.60 -9.30 -11 -23 -12 -8.50
Sale and/or Maturity of Investments
-20 0.00 -20 -55 481 37 20 339 -357 107 -27
Net Cash From Financing Activities
-14 -73 -68 -57 -56 -41 -36 -156 -117 -28 -116
Net Cash From Continuing Financing Activities
-14 -73 -68 -57 -56 -41 -36 -156 -117 -28 -116
Repayment of Debt
-2.20 -55 -38 -50 -79 -25 -25 -170 -80 0.00 -1,310
Other Financing Activities, Net
-12 -18 -30 -7.00 23 -16 -11 14 -37 -28 -6.50

Annual Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,793 6,546 7,163 7,338 7,890 7,949 7,774 7,549 7,677
Cash and Due from Banks
406 895 813 1,075 771 645 768 793 784
Trading Account Securities
7.90 8.70 7.90 115 641 677 708 724 537
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
304 314 299 236 195 173 164 136 133
Goodwill
1,765 1,779 1,969 2,098 2,082 2,066 2,081 1,998 2,058
Intangible Assets
1,306 1,128 1,063 991 922 875 806 690 655
Other Assets
2,004 2,422 3,011 2,823 3,280 3,515 3,248 3,208 3,510
Total Liabilities & Shareholders' Equity
5,793 6,546 7,163 7,338 7,890 7,949 7,774 7,549 7,677
Total Liabilities
5,294 5,186 5,862 6,242 6,442 6,287 6,096 5,794 5,721
Short-Term Debt
60 40 39 40 42 50 150 103 125
Accrued Interest Payable
36 43 60 45 105 33 21 20 29
Other Short-Term Payables
1,870 1,956 2,224 1,981 2,287 2,308 2,227 2,207 2,438
Long-Term Debt
2,784 2,644 2,620 3,236 3,221 3,212 3,097 2,940 2,625
Other Long-Term Liabilities
544 503 919 941 787 685 602 524 504
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
499 1,360 1,301 1,096 1,449 1,662 1,678 1,755 1,956
Total Preferred & Common Equity
499 1,360 1,301 1,095 1,448 1,661 1,677 1,755 1,955
Total Common Equity
499 1,360 1,301 1,095 1,448 1,661 1,677 1,755 1,955
Common Stock
1,735 2,813 2,819 2,866 2,919 2,934 2,980 3,009 3,062
Retained Earnings
-1,149 -1,298 -1,297 -1,528 -1,278 -1,082 -1,117 -986 -898
Accumulated Other Comprehensive Income / (Loss)
-87 -154 -243 -243 -193 -191 -185 -269 -209
Noncontrolling Interest
- - 0.00 0.90 0.80 0.80 0.60 0.50 0.50

Quarterly Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
7,622 7,640 7,582 7,491 7,343 7,534 7,408 7,555 7,691 7,648 7,554
Cash and Due from Banks
460 502 588 554 567 775 623 618 634 601 501
Trading Account Securities
686 682 694 714 711 724 735 732 720 529 531
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
170 166 160 155 148 142 126 124 122 134 146
Goodwill
2,067 2,073 2,052 2,064 2,024 2,049 2,021 2,060 2,055 2,059 2,058
Intangible Assets
858 841 823 791 712 703 682 675 664 645 636
Other Assets
3,382 3,376 3,265 3,213 3,181 3,141 3,220 3,347 3,496 3,680 3,683
Total Liabilities & Shareholders' Equity
7,622 7,640 7,582 7,491 7,343 7,534 7,408 7,555 7,691 7,648 7,554
Total Liabilities
6,042 6,018 6,011 5,866 5,704 5,831 5,631 5,651 5,733 5,695 5,532
Short-Term Debt
34 37 119 125 142 96 109 175 129 130 243
Accrued Interest Payable
6.90 55 7.00 20 28 31 31 64 75 87 41
Other Short-Term Payables
2,080 2,031 2,091 2,035 1,966 2,114 2,063 2,087 2,302 2,210 2,152
Long-Term Debt
3,228 3,226 3,125 3,066 3,002 2,997 2,911 2,820 2,720 2,621 2,415
Other Long-Term Liabilities
694 668 669 620 567 593 517 505 507 648 680
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,580 1,622 1,572 1,625 1,640 1,703 1,777 1,904 1,958 1,953 2,022
Total Preferred & Common Equity
1,579 1,621 1,571 1,625 1,639 1,702 1,776 1,904 1,958 1,952 2,022
Total Common Equity
1,579 1,621 1,571 1,625 1,639 1,702 1,776 1,904 1,958 1,952 2,022
Common Stock
2,939 2,953 2,967 2,978 2,982 2,994 3,015 3,029 3,044 3,057 3,068
Retained Earnings
-1,158 -1,153 -1,187 -1,146 -1,133 -1,099 -984 -927 -875 -910 -858
Accumulated Other Comprehensive Income / (Loss)
-202 -178 -209 -207 -211 -192 -255 -199 -211 -194 -189
Noncontrolling Interest
0.50 0.60 0.50 0.60 0.60 0.60 0.50 0.60 0.50 0.40 0.40

Annual Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - -
Profitability Metrics
- - - - - - - - - -
Valuation Ratios
- - - - - - - - - -
Leverage & Solvency
- - - - - - - - - -
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Efficiency Ratios
- - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - -
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.09) $0.00 ($1.00) $1.12 $0.87 ($0.16) $0.57 $0.38
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 216.60M 219.89M 222.18M 223M 225.40M 226.90M 228.90M 231.20M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.09) $0.00 ($1.00) $1.10 $0.86 ($0.16) $0.56 $0.38
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 216.60M 224.50M 220.80M 226.50M 228M 226.90M 232.80M 234.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($1.09) $0.00 ($1.00) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 171.20M 217.70M 220.80M 224.55M 225.80M 227.33M 229.73M 231.82M
Debt Service Ratios
- - - - - - - - - -
Payout Ratios
- - - - - - - - - -

Quarterly Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 231,821,697.00 234,300,505.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 231,821,697.00 234,300,505.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.05 0.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-67.59% -2.13% -5.48% 3.99% 2.83% 4.94% 8.94% 10.42% - 10.66% 11.29%
EBITDA Growth
102.44% 215.23% 9.14% 131.37% 15.14% 96.04% 69.31% 7.36% - 0.73% 8.02%
EBIT Growth
9,828.57% 70.29% 168.75% 446.41% 50.81% 114.54% 402.16% 32.41% - 31.71% 10.17%
NOPAT Growth
134.23% 70.29% 164.71% 414.66% 61.75% 107.89% 381.10% 137.33% - 142.62% 3.00%
Net Income Growth
134.23% 62.30% 164.71% 199.41% 61.75% 106.60% 324.44% 52.52% - -763.16% -8.03%
EPS Growth
158.33% 61.76% 200.00% 193.33% 58.06% 107.69% 316.67% 57.14% - -600.00% -12.00%
Operating Cash Flow Growth
-16.95% 43.52% 229.76% 4.25% -43.08% -29.50% -55.96% 20.09% - -50.31% 462.50%
Free Cash Flow Firm Growth
137.74% 105.99% 413.55% 445.92% 247.82% 325.54% -156.50% -4.54% - 338.02% 514.39%
Invested Capital Growth
0.02% -0.51% -2.09% -0.40% -2.57% -0.42% 2.43% 0.23% - -1.93% -4.47%
Revenue Q/Q Growth
13.52% -55.45% 4.38% 3.13% 12.25% -13.16% 8.36% 4.54% - -7.65% 8.97%
EBITDA Q/Q Growth
189.32% -77.79% 150.85% 43.51% 43.97% -64.36% 119.63% -23.22% - 9,050.00% 135.52%
EBIT Q/Q Growth
545.10% -138.91% 164.91% 208.14% 93.77% -96.01% 1,602.44% -38.54% - 111.07% 1,324.07%
NOPAT Q/Q Growth
751.73% -126.58% 172.78% 149.63% 235.01% -98.62% 3,268.90% -6.85% - 111.07% 1,286.97%
Net Income Q/Q Growth
305.90% -141.26% 146.88% 149.63% 235.01% -98.32% 2,915.79% -10.30% - 43.75% 518.25%
EPS Q/Q Growth
306.67% -141.94% 146.15% 133.33% 250.00% -97.96% 2,400.00% -12.00% - 50.00% 540.00%
Operating Cash Flow Q/Q Growth
7.60% -161.81% 117.43% 799.54% -41.25% -240.63% 105.93% 2,353.13% - -194.64% 122.18%
Free Cash Flow Firm Q/Q Growth
610.01% -90.77% 1,722.05% -54.28% 352.36% -90.82% -391.07% 159.44% - 64.58% 182.21%
Invested Capital Q/Q Growth
2.26% -2.20% -0.69% 0.28% 0.04% -0.05% 2.16% -1.88% - -0.04% -0.49%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
5.29% 1.38% 3.32% 4.61% 5.92% 2.43% 4.92% 3.62% - 2.21% 4.78%
EBIT Margin
2.71% -1.24% 0.77% 2.30% 3.98% 0.18% 2.87% 1.69% - 0.22% 2.84%
Profit (Net Income) Margin
2.78% -1.35% 0.61% 1.46% 4.37% 0.08% 2.36% 2.02% - -0.51% 1.95%
Tax Burden Percent
99.57% 108.68% 78.49% 63.58% 85.47% 38.00% 75.20% 113.97% - 131.25% 68.18%
Interest Burden Percent
102.94% 100.00% 100.00% 100.00% 128.63% 121.95% 109.17% 105.13% - -177.78% 100.52%
Effective Tax Rate
0.43% 0.00% 21.51% 36.42% 14.53% 62.00% 24.80% -13.97% - 0.00% 31.82%
Return on Invested Capital (ROIC)
5.23% -1.66% 1.14% 2.80% 8.32% 0.14% 4.26% 3.93% - 0.33% 4.21%
ROIC Less NNEP Spread (ROIC-NNEP)
5.23% -1.98% 1.14% 2.80% 8.32% 0.15% 4.42% 4.01% - -0.24% 4.22%
Return on Net Nonoperating Assets (RNNOA)
10.19% -3.98% 2.24% 5.42% 15.24% 0.27% 7.66% 6.51% - -0.38% 6.08%
Return on Equity (ROE)
15.42% -5.63% 3.37% 8.21% 23.56% 0.40% 11.92% 10.44% - -0.05% 10.30%
Cash Return on Invested Capital (CROIC)
-0.45% 0.77% 2.54% 2.23% 4.85% 3.33% 1.34% 4.19% - 3.03% 6.15%
Operating Return on Assets (OROA)
3.20% -1.51% 0.94% 2.80% 4.80% 0.23% 3.68% 2.17% - 0.29% 3.92%
Return on Assets (ROA)
3.28% -1.64% 0.73% 1.78% 5.28% 0.11% 3.02% 2.60% - -0.68% 2.69%
Return on Common Equity (ROCE)
15.42% -5.63% 3.37% 8.21% 23.55% 0.40% 11.92% 10.43% - -0.05% 10.30%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.75% 1.26% 5.18% 0.00% 9.12% 10.81% 11.42% - 3.78% 3.42%
Net Operating Profit after Tax (NOPAT)
70 -19 14 34 113 1.56 52 49 - 3.78 52
NOPAT Margin
2.78% -0.87% 0.61% 1.46% 4.37% 0.07% 2.16% 1.92% - 0.15% 1.94%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.32% 0.00% 0.00% 0.00% -0.01% -0.16% -0.08% - 0.57% -0.01%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Expenses to Revenue
97.29% 101.24% 99.23% 97.70% 96.02% 99.82% 97.13% 98.31% - 99.78% 97.16%
Earnings before Interest and Taxes (EBIT)
68 -27 17 53 103 4.10 70 43 - 5.40 77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
133 30 74 106 153 55 120 92 - 55 129
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.46 1.46 1.45 1.84 1.71 1.32 1.35 1.88 - 1.46 1.55
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Price to Revenue (P/Rev)
0.26 0.26 0.26 0.34 0.32 0.25 0.27 0.38 - 0.28 0.30
Price to Earnings (P/E)
0.00 194.84 115.64 35.43 22.86 14.49 12.44 16.49 - 38.56 45.40
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield
0.00% 0.51% 0.86% 2.82% 4.37% 6.90% 8.04% 6.06% - 2.59% 2.20%
Enterprise Value to Invested Capital (EV/IC)
1.00 1.04 1.04 1.13 1.09 0.99 1.01 1.23 - 1.06 1.13
Enterprise Value to Revenue (EV/Rev)
0.53 0.54 0.55 0.59 0.57 0.51 0.52 0.60 - 0.49 0.51
Enterprise Value to EBITDA (EV/EBITDA)
22.34 18.17 17.57 15.89 14.48 12.19 11.27 13.27 - 18.69 19.14
Enterprise Value to EBIT (EV/EBIT)
0.00 153.37 114.00 48.69 35.87 26.55 21.05 24.08 - 72.05 69.31
Enterprise Value to NOPAT (EV/NOPAT)
0.00 411.07 240.72 61.72 48.03 33.97 27.24 27.84 - 97.36 70.14
Enterprise Value to Operating Cash Flow (EV/OCF)
32.42 20.17 17.27 18.44 25.25 27.73 31.08 29.76 - 19.28 17.46
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 135.18 40.38 50.68 22.28 29.64 76.08 29.35 - 34.75 17.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.93 1.96 1.92 1.82 1.73 1.70 1.57 1.46 - 1.41 1.31
Long-Term Debt to Equity
1.85 1.89 1.83 1.76 1.67 1.64 1.48 1.39 - 1.34 1.19
Financial Leverage
1.95 2.01 1.96 1.94 1.83 1.83 1.73 1.62 - 1.55 1.44
Leverage Ratio
4.71 4.72 4.59 4.62 4.46 4.38 4.20 4.16 - 4.04 3.85
Compound Leverage Factor
4.85 4.72 4.59 4.62 5.74 5.34 4.59 4.37 - -7.18 3.87
Debt to Total Capital
65.93% 66.25% 65.72% 64.49% 63.42% 62.95% 61.14% 59.27% - 58.48% 56.80%
Short-Term Debt to Total Capital
3.04% 2.60% 2.96% 2.01% 2.15% 2.26% 3.57% 2.69% - 2.76% 5.20%
Long-Term Debt to Total Capital
62.89% 63.66% 62.76% 62.48% 61.26% 60.69% 57.57% 56.58% - 55.72% 51.60%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% - 0.01% 0.01%
Common Equity to Total Capital
34.06% 33.74% 34.27% 35.49% 36.57% 37.04% 38.85% 40.72% - 41.51% 43.20%
Debt to EBITDA
14.70 11.56 11.14 9.03 8.39 7.75 6.83 6.41 - 10.30 9.61
Net Debt to EBITDA
11.22 9.56 9.13 6.77 6.20 6.15 5.42 4.98 - 8.05 7.80
Long-Term Debt to EBITDA
14.02 11.11 10.64 8.75 8.11 7.48 6.43 6.12 - 9.81 8.73
Debt to NOPAT
-154.60 261.55 152.59 35.07 27.83 21.62 16.52 13.44 - 53.64 35.21
Net Debt to NOPAT
-118.04 216.18 125.05 26.28 20.57 17.16 13.11 10.45 - 41.93 28.58
Long-Term Debt to NOPAT
-147.47 251.30 145.71 33.98 26.88 20.84 15.56 12.83 - 51.11 31.99
Noncontrolling Interest Sharing Ratio
0.04% 0.03% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% - 0.02% 0.03%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
69 6.35 116 53 239 22 -64 38 - 96 271
Operating Cash Flow to CapEx
1,249.38% -1,191.43% 184.75% 2,086.17% 1,238.71% -3,521.74% 103.23% 2,242.86% - -1,995.90% 635.29%
Free Cash Flow to Firm to Interest Expense
0.00 0.11 1.90 0.96 4.31 0.42 -1.20 0.68 - 1.95 4.55
Operating Cash Flow to Interest Expense
0.00 -2.13 0.36 3.57 2.08 -3.10 0.18 4.21 - -4.95 0.91
Operating Cash Flow Less CapEx to Interest Expense
0.00 -2.31 0.16 3.40 1.91 -3.19 0.01 4.02 - -5.20 0.76
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.18 1.22 1.21 1.22 1.21 1.26 1.28 1.29 - 1.35 1.38
Fixed Asset Turnover
55.12 56.80 57.89 60.83 61.73 66.59 70.29 74.49 - 77.96 77.16
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,925 4,816 4,783 4,796 4,798 4,796 4,899 4,807 - 4,704 4,680
Invested Capital Turnover
1.88 1.91 1.88 1.91 1.90 1.95 1.97 2.04 - 2.14 2.17
Increase / (Decrease) in Invested Capital
1.00 -25 -102 -19 -126 -20 116 11 - -92 -219
Enterprise Value (EV)
4,934 5,015 4,959 5,443 5,252 4,744 4,938 5,901 - 4,993 5,295
Market Capitalization
2,454 2,377 2,382 3,125 3,002 2,348 2,560 3,686 - 2,842 3,137
Book Value per Share
$7.38 $7.13 $7.16 $7.43 $7.65 $7.73 $8.23 $8.45 - $8.42 $8.63
Tangible Book Value per Share
($5.32) ($5.40) ($4.79) ($4.58) ($4.07) ($4.03) ($3.59) ($3.29) - ($3.24) ($2.87)
Total Capital
4,925 4,816 4,783 4,796 4,798 4,796 4,899 4,807 - 4,704 4,680
Total Debt
3,247 3,191 3,143 3,093 3,043 3,019 2,995 2,849 - 2,751 2,658
Total Long-Term Debt
3,097 3,066 3,002 2,997 2,940 2,911 2,820 2,720 - 2,621 2,415
Net Debt
2,479 2,637 2,576 2,318 2,250 2,396 2,377 2,215 - 2,150 2,158
Capital Expenditures (CapEx)
16 11 12 9.40 9.30 4.60 9.30 11 - 12 8.50
Net Nonoperating Expense (NNE)
0.00 10 0.00 0.00 0.00 -0.34 -4.81 -2.51 - 16 -0.27
Net Nonoperating Obligations (NNO)
3,247 3,191 3,143 3,093 3,043 3,019 2,995 2,849 - 2,751 2,658
Total Depreciation and Amortization (D&A)
65 56 57 53 50 50 50 49 - 50 52
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.31 ($0.13) $0.06 $0.15 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05) $0.22
Adjusted Weighted Average Basic Shares Outstanding
226.90M 227.90M 229M 229.30M 228.90M 230.40M 231.40M 231.50M 231.20M 232.80M 234.40M
Adjusted Diluted Earnings per Share
$0.31 ($0.13) $0.06 $0.14 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05) $0.22
Adjusted Weighted Average Diluted Shares Outstanding
226.90M 227.90M 231.50M 233.40M 232.80M 232.30M 232.40M 235.90M 234.70M 232.80M 236.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
227.33M 229.05M 229.25M 229.49M 229.73M 231.29M 231.53M 231.60M 231.82M 234.30M 234.71M
Normalized Net Operating Profit after Tax (NOPAT)
84 -16 25 30 117 7.42 52 30 - 3.78 52
Normalized NOPAT Margin
3.36% -0.76% 1.10% 1.28% 4.52% 0.33% 2.16% 1.18% - 0.15% 1.94%
Pre Tax Income Margin
2.79% -1.24% 0.77% 2.30% 5.11% 0.22% 3.13% 1.77% - -0.39% 2.86%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 -0.45 0.28 0.97 1.85 0.08 1.31 0.77 - 0.11 1.29
NOPAT to Interest Expense
0.00 -0.32 0.22 0.61 2.03 0.03 0.99 0.87 - 0.08 0.88
EBIT Less CapEx to Interest Expense
0.00 -0.63 0.09 0.79 1.68 -0.01 1.14 0.58 - -0.14 1.15
NOPAT Less CapEx to Interest Expense
0.00 -0.49 0.03 0.44 1.87 -0.06 0.81 0.69 - -0.17 0.74
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Cushman & Wakefield (NYSE:CWK) showed a meaningful sequential rebound in the second quarter of 2026. Net income reached $52.7 million, or $0.22 per diluted share, compared with a $12.6 million loss and a $0.05 per-share loss in the first quarter. Revenue increased to $2.71 billion from $2.48 billion in Q1 2026 and was approximately 11% above the restated Q2 2025 figure of $2.43 billion. However, Q2 earnings remained below the $57.3 million reported in Q2 2025, indicating that the recovery is not yet consistently improving on a year-over-year basis.

Cash generation also improved sequentially. Operating cash flow was $54.0 million in Q2 2026, versus negative $243.5 million in Q1, although it remained well below the $235.5 million generated in Q3 2025. The first-half cash-flow picture was still weak because operating working capital consumed $420.8 million, including an $80.2 million use in Q2. This demonstrates that reported earnings are not always translating into cash at a predictable rate.

The balance sheet reflects significant debt reduction but also a sharp decline in liquidity during the quarter. CWK repaid approximately $1.31 billion of debt in Q2, reducing long-term debt to $2.41 billion from $2.62 billion in Q1 and $2.82 billion in Q2 2025. Cash and equivalents, however, fell by $100.1 million sequentially to $500.5 million. Total liabilities remained substantial at $5.53 billion, while goodwill and intangible assets totaled approximately $2.69 billion, or roughly 36% of total assets. Investors should also note that several historical income-statement and cash-flow figures have been restated, which may affect comparisons with previously reported results.

  • Quarterly profitability recovered: Q2 2026 net income of $52.7 million reversed the $12.6 million loss recorded in Q1 2026.
  • Revenue growth improved: Q2 2026 revenue of $2.71 billion was up approximately 11% from the restated Q2 2025 figure of $2.43 billion.
  • Debt reduction was substantial: CWK repaid $1.31 billion during Q2, and total short- and long-term debt declined to approximately $2.66 billion from $3.00 billion a year earlier.
  • Interest expense has generally moved lower over the longer term: Quarterly interest expense declined from $76.8 million in Q1 2023 to $49.2 million in Q1 2026, although it increased to $59.6 million in Q2 2026.
  • Shareholders’ equity improved: Total equity and noncontrolling interests rose to $2.02 billion in Q2 2026 from $1.95 billion in Q1 and $1.90 billion in Q2 2025, helped by improved retained earnings.
  • Operating cash flow is volatile: Cash from operations was positive in Q2 2026 but swung from negative $243.5 million in Q1 to positive $54.0 million, following positive $257.3 million in Q4 2025 and negative $162.0 million in Q1 2025.
  • Investment activity has materially affected cash flows: CWK has alternated between sizable purchases and sales or maturities of investment securities, making quarterly investing cash flow difficult to interpret as a recurring operating trend.
  • Working capital remains a cash-flow headwind: Changes in operating assets and liabilities used $80.2 million in Q2 2026 and $340.6 million in Q1, contributing to negative first-half operating cash flow.
  • Liquidity declined after the debt repayment: Cash and equivalents fell from $600.6 million at the end of Q1 2026 to $500.5 million at the end of Q2, limiting the cushion available for future obligations.
  • Profitability remains inconsistent: CWK reported losses in Q1 2024, Q1 2025, Q4 2025 and Q1 2026, while earnings have been supported by highly variable non-interest income and investment gains or losses.
09/10/26 08:23 AM ETAI Generated. May Contain Errors.

Cushman & Wakefield Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cushman & Wakefield's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cushman & Wakefield's net income appears to be on a downward trend, with a most recent value of $88.20 million in 2025, falling from -$434.60 million in 2016. The previous period was $131.30 million in 2024. Check out Cushman & Wakefield's forecast to explore projected trends and price targets.

Over the last 9 years, Cushman & Wakefield's total revenue changed from -$165.90 million in 2016 to $9.90 billion in 2025, a change of -6,069.7%.

Cushman & Wakefield's total liabilities were at $5.72 billion at the end of 2025, a 1.3% decrease from 2024, and a 8.1% increase since 2017.

In the past 8 years, Cushman & Wakefield's cash and equivalents has ranged from $405.60 million in 2017 to $1.07 billion in 2020, and is currently $784.20 million as of their latest financial filing in 2025.



Financial statements for NYSE:CWK last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners